This contract adds over $1B in government revenue visibility for FY2026, reinforcing McKesson's stable government segment. Traders should watch for follow-on task orders and any margin commentary on the government distribution business in upcoming earnings calls.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 1 $733.09entry
- T+1 · 6mo ago +0.42%α +0.27% · $736.15
- T+5 · 5mo ago +5.81%α +8.56% · $775.66
- T+20 · 5mo ago +1.97%α +4.28% · $747.53
- T+60 · 3mo ago +22.92%α +21.95% · $901.12
Price Chart
How similar events traded
Executive Summary
McKesson Corporation was awarded a $1.19 billion contract by the Department of Veterans Affairs as the Pharmaceutical Prime Vendor for FY2026 April. This is a large, sole-source award that reinforces McKesson's dominant position as a government pharmaceutical distributor and provides significant revenue visibility.
Key Financial Metrics
Key Facts
- Award amount: $1,191,348,080.87
- Awarding agency: Department of Veterans Affairs
- Contract type: Pharmaceutical Prime Vendor (PPV) for FY2026 April
- Start date: 2026-04-01
- Recipient match verified: McKesson Corporation is the named recipient
Financial Impact
The $1.19B award represents approximately 0.7% of McKesson's annual revenue (based on FY2025 revenue of ~$170B), which is a notable but not transformative addition to a large revenue base.
Risk Factors
- Government contracts are subject to funding availability and continuing resolutions
- Government distribution margins are typically lower than commercial business
- Execution risk on large-volume pharmaceutical distribution
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 federal contract record from official U.S. government contract data.
| Document | Accession Number |
|---|---|
| GOVT-CONTRACT Data (Synthetic) | contract-36C24026K1007 |
Track record
26 reports on MCK
4 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +16.91% at T+60 after the Aug 1, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $1,072.00 to $1,077.05 Now $1,102.81 +2.87% ▲ +0.47% −2.82% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $1,072.00 to $1,077.05 Now $1,102.81 +2.87% ▲ +0.47% −2.82% vs SPY
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $1,072.00 to $1,077.05 Now $1,102.81 +2.87% ▲ +0.47% −2.82% vs SPY
- Oct 30, 202617d ago 25-NSE Neutral 1/10 Entry $994.58 to $1,060.84 Now $1,102.81 +10.88% ▲ +6.66% +9.37% vs SPY
- Oct 28, 202619d ago Institutional Cluster Neutral 3/10 Entry $960.56 to $1,069.44 Now $1,102.81 +14.81% ▲ +11.34% +12.05% vs SPY
- Oct 27, 202621d ago GOVT-CONTRACT Neutral 3/10 Entry $960.56 to $1,069.44 Now $1,102.81 +14.81% ▲ +11.34% +12.05% vs SPY
- Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $955.76 to $1,010.43 Now $1,102.81 +15.39% ▲ +5.72% +7.21% vs SPY
- Oct 6, 20265w ago 8-K Bullish 6/10 Entry $921.67 to $961.88 Now $1,102.81 +19.65% ▲ +4.36% +4.50% vs SPY
- Sep 1, 202611w ago GOVT-CONTRACT Neutral 3/10 Entry $924.78 to $880.86 Now $1,102.81 +19.25% ▼ −4.75% −3.79% vs SPY
- Aug 28, 202611w ago 8-K Neutral 4/10 Entry $885.32 to $896.29 Now $1,102.81 +24.57% ▲ +1.24% +1.38% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers